Cresco Labs Inc.
Cresco Labs Inc. is a U.S.-based cannabis company that grows, processes, brands, and distributes cannabis products through a consumer-packaged-goods style model. It also operates Sunnyside retail dispensaries and supports its business with cultivation, production, and legislative advocacy activities.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaPackaged cannabis goods sold under Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi.
Direct-to-consumer cannabis sales through Sunnyside dispensaries.
Distribution of cannabis products to third-party retail channels and partners.
Growing, processing and packaging cannabis products for internal brands and channels.
Asiakkaat
Cresco Labs serves adult-use consumers and medical cannabis patients who buy through its Sunnyside dispensaries or through retail partners carrying its brands. It also sells to wholesale customers and dispensary networks that want branded cannabis flower, vapes, edibles, and wellness products. The business is built around consumer demand for regulated cannabis products and retailers that value consistent supply, branding, and compliance.
Buy branded cannabis flower, vapes, edibles and pre-rolls for recreational use.
Buy products through dispensaries for symptom relief and ongoing access.
Purchase Cresco brands for resale in licensed retail channels.
Visit Sunnyside locations for direct purchases and product education.
Strategia
Cresco Labs’ strategy is to build national cannabis brands with a consumer-packaged-goods mindset while keeping a strong direct retail channel through Sunnyside. It also emphasizes regulatory engagement, community outreach, and scale in cultivation and distribution to support product availability and brand recognition.
A recognizable brand portfolio helps differentiate products in a crowded regulated market.
Owning retail touchpoints improves customer education, trust, and repeat purchases.
Cannabis markets depend on licensing and policy changes, so advocacy supports market access.
Reliable supply and product consistency are important for brand execution and wholesale distribution.
Maantiede
Cresco Labs operates nationally in the United States, with cultivation, production, wholesale distribution, and retail dispensary activity spread across multiple state markets. The company also uses Canadian capital markets for financing and disclosure, but its operating footprint and revenue base are centered in U.S. regulated cannabis states. Geography matters because cannabis regulation, licensing, and retail access are determined state by state.
Riskit
Cresco Labs faces cannabis-industry risks tied to regulation, licensing, and shifting state-level market rules, which can affect product availability and retail access. The business also depends on brand execution, wholesale channel relationships, and the continuity of controlled-substance compliance, while accounting and tax treatment can be unusual relative to standard consumer companies.
- Cannabis regulatory changeVaikutus: KorkeaTodennäköisyys: Korkea
Sales and operations depend on state licensing, product rules, and enforcement priorities.
Kohdistuu: U.S. state cannabis markets
- Compliance and licensing riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
A regulated controlled-substance business can be disrupted by licensing issues or violations.
Kohdistuu - Cannabis tax treatmentVaikutus: KorkeaTodennäköisyys: Kohtalainen
Tax positions and the applicability of IRC 280E can materially affect cash taxes and reported results.
Kohdistuu: U.S. operations
- Wholesale channel concentrationVaikutus: KeskitasoTodennäköisyys: Kohtalainen
A meaningful share of product volume may rely on third-party retailers and distribution partners.
Kohdistuu: Branded product distribution
Kirjanpito
Harkinnanvaraiset erätCultivation and processing costs must be allocated carefully, affecting cost of sales and gross margin.
Vaikutus: Cannabis inventory is subject to compliance and quality-related write-down risk
Brand and acquisition values can be impaired if market conditions or cash flows weaken.
Vaikutus: Could create non-cash charges and reduce reported equity
The company consolidates entities it controls economically, affecting assets, liabilities, and revenue presentation.
Vaikutus: Changes consolidation scope and balance sheet size
Tax treatment in cannabis is unusual and can alter tax expense, liabilities, and distributions.
Vaikutus: Affects effective tax rate and tax-related assets/liabilities
Ownership interests in subsidiaries require allocation of income and required tax distributions.
Vaikutus: Affects net income attributable to shareholders and equity
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Verano Holdings Corp.
VRNO · Agricultural Production-Crops
SNDL Inc.
SNDL · Medicinal Chemicals & Botanical Products
Vireo Growth Inc.
VREOF · Pharmaceutical Preparations
Planet 13 Holdings Inc.
PLNH · Agricultural Production-Crops
Ayr Wellness Inc.
AYRWF · Medicinal Chemicals & Botanical Products
TerrAscend Corp.
TSNDF · Agricultural Production-Crops
Päivitetty: 28.9.2026